Feasibility and toxicity of high-dose chemotherapy supported by peripheral blood stem cell transplantation in elderly patients (>/=60 years) with non-Hodgkin's lymphoma: comparison with patients <60 years treated within the same protocol.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples